BeStock  
Stocks › Biotechnology › OMER

Omeros OMER

US equityMarket cap rank #3176Biotechnology
$13.21 −$0.80 (-5.71%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $13.19 -0.15%
Open$13.78
Prev close$14.01
Day range$13.07 – $13.88
Volume2.02M
Market cap$983.66M
P/E (TTM)8.5
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings10.1x
CheapRich

Near the top of its 5-year range · 90th percentile, 5-year average -4.7x

#607 of 2991 stocks by PE (1 = cheapest)

Price / book-24.7x
CheapRich

Near the bottom of its 5-year range · 9th percentile, 5-year average -6.0x

Price / sales33.0x
CheapRich

Near the top of its 5-year range · 91st percentile, 5-year average 6.1x

#4818 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-323x-195x-66x63xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$19.57
Price vs. fair value-32.5%Trading below the estimate
Star rating★★★☆☆
Economic moatNarrow
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB -24.67 – -6.00 9% (cheaper than usual) –
PE 10.11 16.91 -4.68 90% (pricier than usual) #607 of 2991 (1 = cheapest)
PS 32.95 7.26 6.12 91% (pricier than usual) #4818 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on OMER.

Sign in to join the discussion.

Scroll to Top